METHOD OF CORRECTION OF THE LOCALIZED SCLERODERMA
##semicolon##
Key words: localized scleroderma, lipofilling, maxillofacial area.##article.abstract##
Annotation. Localized scleroderma (LS) is an inflammatory sclerosing disease
of the skin and subcutaneous tissues associated with their atrophy. Depending on the
subtype, severity of the disease and localization of the lesion, involvement in the
pathological process of adipose tissue, muscles, joints and bones, but not internal
organs, is noted. The annual primary incidence of drugs in childhood is 3.4 cases per
1,000,000 child population; in females, the disease occurs 2.6–6 times more often. The
wide range of clinical manifestations of the disease has led to the emergence of a large
number of different classifications, which take into account the severity, prevalence
and depth of the fibrosis process, as a result of which five main clinical forms of LS
are distinguished: limited, generalized, linear, deep and mixed. The forms of drugs are
not mutually exclusive, since the same patient may experience different manifestations
of the disease. One of the most common forms of LS in childhood is the linear form,
which is observed in approximately 40–70% of children.
##submission.citations##
List of references used:
1. ELFadl D., Garimella V., Mahapatra TK et al. Lipomodeling of the breast: a review.
Breast. 2010;19(3):202-9.
2. Leopardi D. et al. Systematic review of autologous fat transfer for cosmetic and
reconstructive breast augmentation. Adelaide, South Australia: ASERNIP-S, 2010.
3. Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal
technique with 25 years of experience. Aesthetic Plast Surg. 2009;33(5): 706-15.
4. Gutowski K.A.; ASPS Fat Graft Task Force. Current applications and safety of
autologous fat grafts: a report of the ASPS fat graft task force. Plast Reconstr Surg.
2009;124(1):272-80.
5. Schultz I., Lindegren A., Wickman M. Improved shape and consistency after
lipofilling of the breast: patients' evaluation of the outcome. J Plast Hand Surg.
2012;46(2):85-90.
6. Coleman SR Facial augmentation with structural fat grafting. Clin Plast Surg.
2006;33(4):567-77.
7. Ozsoy Z., Kul Z., Bilir A. The role of cannula diameter in improved adipocyte
viability: a quantitative analysis. Aesthet Surg J 2006;26(3):287-9.
8. Erdim M., Tezel E., Numanoglu A., Sav A. The effects of the size of liposuction
cannula on adipocyte survival and the optimum temperature for fat graft storage: an
experimental study. J Plast Reconstr Aesthet Surg.
9. 2009;62(9):1210-4.
10. Leong DT, Hutmacher DW, Chew FT, Lim TC Viability and adipogenic potential
of human adipose tissue processed cell population obtained from pump-assisted and
syringe-assisted liposuction. J Dermatol Sci. 2005;37(3):169-76.
11. Smith P., Adams WP Jr., Lipschitz AH et al. Autologous human fat grafting: effect
of harvesting and preparation techniques on adipocyte graft survival. Plast Reconstr
Surg. 2006;117(6):1836-44.
12. Vona-Davis L., Rose DP Adipokines as endocrine, paracrine, and autocrine factors
in breast cancer risk and progression. Endocr Relat Cancer. 2007;14(2):189-206.
